98 related articles for article (PubMed ID: 8137729)
1. Desethylamiodarone is a noncompetitive inhibitor of the binding of thyroid hormone to the thyroid hormone beta 1-receptor protein.
Bakker O; van Beeren HC; Wiersinga WM
Endocrinology; 1994 Apr; 134(4):1665-70. PubMed ID: 8137729
[TBL] [Abstract][Full Text] [Related]
2. Structure-function relationship of the inhibition of the 3,5,3'-triiodothyronine binding to the alpha1- and beta1-thyroid hormone receptor by amiodarone analogs.
van Beeren HC; Bakker O; Wiersinga WM
Endocrinology; 1996 Jul; 137(7):2807-14. PubMed ID: 8770901
[TBL] [Abstract][Full Text] [Related]
3. Desethylamiodarone is a competitive inhibitor of the binding of thyroid hormone to the thyroid hormone alpha 1-receptor protein.
van Beeren HC; Bakker O; Wiersinga WM
Mol Cell Endocrinol; 1995 Jul; 112(1):15-9. PubMed ID: 7589780
[TBL] [Abstract][Full Text] [Related]
4. Effect of mutations in the beta1-thyroid hormone receptor on the inhibition of T3 binding by desethylamiodarone.
van Beeren HC; Bakker O; Chatterjee VK; Wiersinga WM
FEBS Lett; 1999 Apr; 450(1-2):35-8. PubMed ID: 10350052
[TBL] [Abstract][Full Text] [Related]
5. Desethylamiodarone antagonizes the effect of thyroid hormone at the molecular level.
Bogazzi F; Bartalena L; Brogioni S; Burelli A; Raggi F; Ultimieri F; Cosci C; Vitale M; Fenzi G; Martino E
Eur J Endocrinol; 2001 Jul; 145(1):59-64. PubMed ID: 11415853
[TBL] [Abstract][Full Text] [Related]
6. Beta-adrenergic receptors, voltage-operated Ca(2+)-channels, nuclear triiodothyronine receptors and triiodothyronine concentration in pig myocardium after long-term low-dose amiodarone treatment.
Gøtzsche LB
Acta Endocrinol (Copenh); 1993 Oct; 129(4):337-47. PubMed ID: 8237253
[TBL] [Abstract][Full Text] [Related]
7. Desethylamiodarone interferes with the binding of co-activator GRIP-1 to the beta 1-thyroid hormone receptor.
van Beeren HC; Bakker O; Wiersinga WM
FEBS Lett; 2000 Sep; 481(3):213-6. PubMed ID: 11007966
[TBL] [Abstract][Full Text] [Related]
8. Thyroxine, 3,5,3'-triiodothyronine, and 3,3',5'-triiodothyronine concentrations in several tissues of the rat: effects of amiodarone and desethylamiodarone on thyroid hormone metabolism [corrected].
Schröder-van der Elst JP; van der Heide D
Endocrinology; 1990 Oct; 127(4):1656-64. PubMed ID: 2401231
[TBL] [Abstract][Full Text] [Related]
9. Interaction of amiodarone and desethylamiodarone with solubilized nuclear thyroid hormone receptors.
Latham KR; Sellitti DF; Goldstein RE
J Am Coll Cardiol; 1987 Apr; 9(4):872-6. PubMed ID: 3558985
[TBL] [Abstract][Full Text] [Related]
10. Amiodarone is a dose-dependent noncompetitive and competitive inhibitor of T3 binding to thyroid hormone receptor subtype beta 1, whereas disopyramide, lignocaine, propafenone, metoprolol, dl-sotalol, and verapamil have no inhibitory effect.
Drvota V; Carlsson B; Häggblad J; Sylvén C
J Cardiovasc Pharmacol; 1995 Aug; 26(2):222-6. PubMed ID: 7475046
[TBL] [Abstract][Full Text] [Related]
11. Effects of adenosine triphosphate and alkaline phosphatase on solubilized 3,5,3'-triiodothyronine-binding activity.
Faure R; Dussault JH
Endocrinology; 1988 Sep; 123(3):1245-52. PubMed ID: 3402384
[TBL] [Abstract][Full Text] [Related]
12. Desethylamiodarone prolongation of cardiac repolarization is dependent on gene expression: a novel antiarrhythmic mechanism.
Drvota V; Blange I; Häggblad J; Sylvén C
J Cardiovasc Pharmacol; 1998 Oct; 32(4):654-61. PubMed ID: 9781936
[TBL] [Abstract][Full Text] [Related]
13. Does amiodarone inhibit T3 binding to solubilized nuclear receptors in vitro?
Wilson BD
Horm Metab Res; 1989 Sep; 21(9):483-8. PubMed ID: 2583673
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone receptors from liver nuclei: characteristics of receptor from normal, thyroidectomized, and triiodothyronine-treated rats; measurement of occupied and unoccupied receptors, and chromatin binding of receptors.
Bernal J; Coleoni AH; DeGroot LJ
Endocrinology; 1978 Aug; 103(2):403-13. PubMed ID: 217646
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of thyroid hormone action by amiodarone in rat pituitary tumor cells.
Norman MF; Lavin TN
J Clin Invest; 1989 Jan; 83(1):306-13. PubMed ID: 2910914
[TBL] [Abstract][Full Text] [Related]
16. Cardiac triiodothyronine nuclear receptor binding capacities in amiodarone-treated, hypo- and hyperthyroid rats.
Gøtzsche LB; Orskov H
Eur J Endocrinol; 1994 Mar; 130(3):281-90. PubMed ID: 8156103
[TBL] [Abstract][Full Text] [Related]
17. Regulation of thyroid hormone receptors and responses by thyrotropin-releasing hormone in GH4C1 cells.
Kaji H; Hinkle PM
Endocrinology; 1987 Nov; 121(5):1697-704. PubMed ID: 3117521
[TBL] [Abstract][Full Text] [Related]
18. Effects of amiodarone on thyroid hormone-responsive gene expression in rat liver.
Hartong R; Wiersinga WM; Lamers WH; Plomp TA; Broenink M; van Beeren MH
Horm Metab Res Suppl; 1987; 17():34-43. PubMed ID: 2895059
[TBL] [Abstract][Full Text] [Related]
19. An essential role of domain D in the hormone-binding activity of human beta 1 thyroid hormone nuclear receptor.
Lin KH; Parkison C; McPhie P; Cheng SY
Mol Endocrinol; 1991 Apr; 5(4):485-92. PubMed ID: 1922081
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone receptors and 3,5,3'-triiodothyronine biological effects in FRTL5 thyroid follicular cells.
Akiguchi I; Strauss K; Borges M; Silva JE; Moses AC
Endocrinology; 1992 Sep; 131(3):1279-87. PubMed ID: 1324156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
